A new trial found that about 30 percent of the weight people lose on tirzepatide is muscle, and a second drug can cut that in half
Medical Research & Innovations · · 5 min read

A new trial found that about 30 percent of the weight people lose on tirzepatide is muscle, and a second drug can cut that in half

Roughly 30 percent of the weight people lose on tirzepatide, the drug sold as Zepbound and Mounjaro, isn’t fat. It’s lean mass, made up mostly of skeletal muscle. This has…

Read article →
Thursday, June 18, 2026 Published today: 1 articles
Scientists discovered that drugs designed for weight loss may reduce breast cancer risk by nearly one-third

Scientists discovered that drugs designed for weight loss may reduce breast cancer risk by nearly one-third

Most people think of Ozempic, Wegovy, Mounjaro, and Zepbound as weight-loss drugs. Some see them as diabetes medications. Others see them as appetite suppressants that accidentally became one of the…

Page 1 of 6